| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 11/21/2023 | 18.03% | Piper Sandler | $34 → $36 | Maintains | Overweight |
| 11/20/2023 | 18.03% | Raymond James | $30 → $36 | Maintains | Strong Buy |
| 11/08/2023 | 31.15% | Truist Securities | $35 → $40 | Maintains | Buy |
| 10/13/2023 | 8.2% | JMP Securities | $32 → $33 | Maintains | Market Outperform |
| 10/06/2023 | 4.92% | Piper Sandler | $27 → $32 | Maintains | Overweight |
| 08/22/2023 | -1.64% | Raymond James | $28 → $30 | Maintains | Strong Buy |
| 08/14/2023 | -8.2% | BMO Capital | $27 → $28 | Maintains | Market Perform |
| 08/09/2023 | 4.92% | JMP Securities | $30 → $32 | Maintains | Market Outperform |
| 07/31/2023 | -11.48% | BMO Capital | → $27 | Initiates Coverage On | → Market Perform |
| 07/12/2023 | -1.64% | JMP Securities | $28 → $30 | Maintains | Market Outperform |
| 05/25/2023 | -8.2% | Raymond James | $25 → $28 | Maintains | Strong Buy |
| 05/22/2023 | -8.2% | JMP Securities | $26 → $28 | Maintains | Market Outperform |
| 05/15/2023 | -11.48% | Keefe, Bruyette & Woods | $25 → $27 | Maintains | Outperform |
| 05/15/2023 | 11.48% | Truist Securities | $26 → $34 | Maintains | Buy |
| 05/11/2023 | -11.48% | Barclays | $23 → $27 | Maintains | Overweight |
| 05/10/2023 | -14.75% | JMP Securities | $25 → $26 | Maintains | Market Outperform |
| 04/18/2023 | -18.03% | Keefe, Bruyette & Woods | $24 → $25 | Maintains | Outperform |
| 04/18/2023 | -18.03% | JMP Securities | → $25 | Reiterates | → Market Outperform |
| 04/18/2023 | -18.03% | Raymond James | $23 → $25 | Maintains | Strong Buy |
| 04/17/2023 | -18.03% | Keefe, Bruyette & Woods | $24 → $25 | Maintains | Outperform |
| 04/12/2023 | -24.59% | Barclays | $22 → $23 | Maintains | Overweight |
| 03/02/2023 | -24.59% | Raymond James | $22 → $23 | Maintains | Strong Buy |
| 03/01/2023 | -18.03% | JMP Securities | $25 → $25 | Maintains | Market Outperform |
| 02/07/2023 | -27.87% | Raymond James | → $22 | Initiates Coverage On | → Strong Buy |
| 02/07/2023 | -18.03% | JMP Securities | → $25 | Initiates Coverage On | → Market Outperform |
| 02/07/2023 | -14.75% | Truist Securities | → $26 | Initiates Coverage On | → Buy |
| 02/07/2023 | -21.31% | Keefe, Bruyette & Woods | → $24 | Initiates Coverage On | → Outperform |
| 02/07/2023 | -24.59% | Piper Sandler | → $23 | Initiates Coverage On | → Overweight |
What is the target price for Skyward Specialty (SKWD)?
The latest price target for Skyward Specialty (NASDAQ: SKWD) was reported by Piper Sandler on November 21, 2023. The analyst firm set a price target for $36.00 expecting SKWD to rise to within 12 months (a possible 18.03% upside). 28 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Skyward Specialty (SKWD)?
The latest analyst rating for Skyward Specialty (NASDAQ: SKWD) was provided by Piper Sandler, and Skyward Specialty maintained their overweight rating.
When is the next analyst rating going to be posted or updated for Skyward Specialty (SKWD)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Skyward Specialty, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Skyward Specialty was filed on November 21, 2023 so you should expect the next rating to be made available sometime around November 21, 2024.
Is the Analyst Rating Skyward Specialty (SKWD) correct?
While ratings are subjective and will change, the latest Skyward Specialty (SKWD) rating was a maintained with a price target of $34.00 to $36.00. The current price Skyward Specialty (SKWD) is trading at is $30.50, which is out of the analyst's predicted range.